LEVBIO — Level Bio AB (publ) Share Price
Last trade - 00:00- SEK29.96m
- SEK28.88m
- SEK25.10m
- 26
- 13
- 59
- 20
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.17 | ||
| Price to Tang. Book | 27.49 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.19 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -177.3% | ||
| Return on Equity | -107.9% | ||
| Operating Margin | -32.21% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 23.71 | 44.65 | 34.68 | 26.1 | 25.1 | n/a | n/a | 7.86% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +209.67 | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Level Bio AB (publ), formerly Alphahelix Molecular Diagnostics publ AB, is a Sweden-based company active in medical technology. The Company conducts research and development of patented technology that enables the identification of viruses and bacteria. Level Bio is the parent company in the group, with operations in the subsidiaries CyberGene and Techtum Lab. CyberGene develops and manufactures diagnostic kits for the clinical market. Techtum Lab is a reputable distributor and full-service partner to molecular biology labs in the Nordics. The products are sold under several brands and via its own distributors, mainly to laboratories and research institutes. The biggest activity is found within the Nordic market. The head office is in Nacka.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 16th, 1998
- Public Since
- September 15th, 2006
- No. of Employees
- 11
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Nordic Growth Market - Stockholm
- Shares in Issue
- 68,398,899
- Address
- Fannys Vag 5, NACKA, 131 54
- Web
- https://levelbio.se/
- Phone
- +46 18120701
- Auditors
- Baker Tilly Sverige AB
Upcoming Events for LEVBIO
Similar to LEVBIO
Prolight Diagnostics AB (publ)
Nordic Growth Market - Stockholm
FAQ
As of Today at 21:44 UTC, shares in Level Bio AB (publ) are trading at SEK0.44. This share price information is delayed by 15 minutes.
Shares in Level Bio AB (publ) last closed at SEK0.44 and the price had moved by +26.59% over the past 365 days. In terms of relative price strength the Level Bio AB (publ) share price has outperformed the FTSE Global All Cap Index by +23.42% over the past year.
There is no consensus recommendation for this security.
Find out moreLevel Bio AB (publ) does not currently pay a dividend.
Level Bio AB (publ) does not currently pay a dividend.
Level Bio AB (publ) does not currently pay a dividend.
To buy shares in Level Bio AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK0.44, shares in Level Bio AB (publ) had a market capitalisation of SEK29.96m.
Here are the trading details for Level Bio AB (publ):
- Country of listing: Sweden
- Exchange: NGM
- Ticker Symbol: LEVBIO
Based on an overall assessment of its quality, value and momentum Level Bio AB (publ) is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Level Bio AB (publ). Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +8.27%.
As of the last closing price of SEK0.44, shares in Level Bio AB (publ) were trading +35.09% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Level Bio AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.44.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Level Bio AB (publ)'s management team is headed by:
- Mikael Havsjo - CHM
- Mattias Molin - PRE
- Ulrica Karlsson - CFO
- Artur Aira - DRC